Stratec reaffirms 2026 targets for Stratec stock
Published on 10/20/2026 at 12:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and operating figures
- H1 2026 sales reached EUR 112.50 million on September 21, 2026.
- Second-quarter revenue reached EUR 59.10 million on August 14, 2026.
- Stratec stock trades at EUR 23.08 at 12:29 p.m. CEST at Lang & Schwarz on October 20, 2026, 0.57 percent above the Xetra close of October 19, 2026.
Stratec (ISIN DE000STRA555) was trading at EUR 23.08 at Lang & Schwarz on October 20, 2026 at 12:29 p.m. CEST, up 0.57 percent versus the Xetra close of October 19, 2026 at EUR 22.95. The company reaffirmed its 2026 targets in an investor presentation dated October 1, 2026, according to TradingView. For investors, the key test is whether the second half can convert stronger system sales into higher profitability.
Targets depend on second half
The October 1 presentation linked Q2 momentum and systems growth with unchanged guidance for 2026. That message followed first-half sales of EUR 112.50 million, reported in the September 21 investor presentation, with the same source describing the growth and profitability targets as reaffirmed.
Second-quarter revenue reached EUR 59.10 million, according to the financial statement data for the period ended June 30, 2026. The figure was above the EUR 53.43 million reported for the first quarter ended March 31, 2026, giving Stratec a concrete sequential improvement in quarterly revenue.
Three dated steps shaped the story
On August 14, 2026, Stratec published its second-quarter results with revenue of EUR 59.10 million. On September 21, 2026, its investor presentation put first-half sales at EUR 112.50 million. On October 1, 2026, the company presentation said Q2 momentum supported unchanged 2026 guidance, according to TradingView.
What does the next report add?
The next scheduled reporting date is November 12, 2026, according to TradingView. That publication should show whether the revenue improvement visible between the first and second quarters was sustained and whether the unchanged targets remain achievable.
Stratec stock stays above the close
The Lang & Schwarz quote places Stratec stock EUR 0.13 above the Xetra close of October 19, 2026. The daily comparison is modest, so the operating figures and the November reporting date provide the stronger context for the quotation.
The further course of trading is shown by the continuously updated real-time quote of Stratec stock.
Stratec stock key figures
- Company: Stratec SE
- ISIN: DE000STRA555
- WKN: STRA55
- Ticker: SBS
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 20, 2026, 12:29 p.m. CEST): EUR 23.08
- Change versus Xetra close: plus 0.57 percent
- Xetra close (October 19, 2026): EUR 22.95
- Market capitalization: EUR 287.5 million (as of October 19, 2026)
- Sector / Industry: Pharma and healthcare / medical technology
- Index membership: CDAX Prime All Share and DAXsubsector Medical Technology
- Next earnings date: November 12, 2026
Market context: Market report DAX.
